In the last trading session, 64670.0 shares of the Journey Medical Corp (NASDAQ:DERM) were traded, and its beta was 0.81. Most recently the company’s share price was $7.00, and it changed around $0.18 or 2.64% from the last close, which brings the market valuation of the company to $163.07M. DERM currently trades at a discount to its 52-week high of $8.24, offering almost -17.71% off that amount. The share price’s 52-week low was $3.44, which indicates that the current value has risen by an impressive 50.86% since then.
Journey Medical Corp stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended DERM as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Journey Medical Corp is expected to report earnings per share of 0 for the current quarter.
Journey Medical Corp (NASDAQ:DERM) trade information
Instantly DERM has showed a green trend with a performance of 2.64% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 7.07 on recent trading dayincreased the stock’s daily price by 0.99%. The company’s shares are currently up 79.03% year-to-date, but still up 0.94% over the last five days. On the other hand, Journey Medical Corp (NASDAQ:DERM) is -7.41% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $10.5, which translates to bulls needing to increase their stock price by 33.33% from its current value. Analyst projections state that DERM is forecast to be at a low of $10.5 and a high of $10.5.
Journey Medical Corp (DERM) estimates and forecasts
The year-over-year growth rate is expected to be 26.46%, up from the previous year.
Consensus estimates provided by 4 financial analysts predict the company will bring in an average of 14.93M in revenue for the current quarter. 4 analysts expect Journey Medical Corp to make 19.52M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 14.86M and 14.63M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 0.53%. Forecasts for the next quarter put sales growth at 33.46%.
DERM Dividends
Journey Medical Corp’s next quarterly earnings report is expected to be released in June.
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC., with 1.4752% or 0.29 million shares worth $1.66 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
WASATCH FUNDS TRUST-Wasatch Micro Cap Value Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 422.78 shares worth $2.96 million, making up 2.44% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 211.45 shares worth around $1.48 million, which represents about 1.22% of the total shares outstanding.
